Document is current
Any future updates will be listed below
-
Authors
Schmallenbach, Leo https://orcid.org/0000-0001-5302-2578
Bärnighausen, Till W.
Lerchenmueller, Marc J. https://orcid.org/0000-0001-8875-3602
-
Funding
Funding for this research was provided by:
Joachim Herz Stiftung
- License Information
-
More Information
Article History
Received: 8 June 2023
Accepted: 15 August 2024
First Online: 12 September 2024
Competing interests
: MJL is a co-founder and shareholder of AaviGen GmbH, a cardiovascular gene therapy company. The present study is not related to the company. The remaining authors declare no competing interests.
